Mark James Kontny — Insider Trading History & SEC Filings
SEC CIK 1517835 — President Global Pharmaceutica
Mark James Kontny is a corporate insider tracked via SEC EDGAR filings. Officers, directors, and 10%+ beneficial owners must report transactions in their company's stock on Form 4, typically within two business days. This page shows Mark James Kontny's reported transactions, current holdings across companies, and filing history.
Frequently asked questions
Who is Mark James Kontny?
Mark James Kontny is a corporate insider (SEC CIK 1517835) with reported roles including President Global Pharmaceutica. This page tracks their SEC Form 4, Form 3, and Form 5 filings, current holdings, and transaction history.
How current is this insider data?
Insiders must report transactions to the SEC typically within two business days. finshort ingests new EDGAR filings continuously, so transactions appear shortly after they are filed.